GW&K Investment Management’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.1M | Sell |
1,048,472
-55,836
| -5% | -$535K | 0.09% | 249 |
|
|
2025
Q1 | $6.92M | Buy |
1,104,308
+1,503
| +0.1% | +$9.42K | 0.06% | 265 |
|
|
2024
Q4 | $8.96M | Sell |
1,102,805
-23,278
| -2% | -$189K | 0.08% | 263 |
|
|
2024
Q3 | $20.4M | Buy |
1,126,083
+525,640
| +88% | +$9.5M | 0.17% | 201 |
|
|
2024
Q2 | $6.19M | Buy |
600,443
+32,417
| +6% | +$334K | 0.06% | 270 |
|
|
2024
Q1 | $6.03M | Buy |
568,026
+6,536
| +1% | +$69.4K | 0.05% | 269 |
|
|
2023
Q4 | $5.13M | Sell |
561,490
-15,960
| -3% | -$146K | 0.05% | 266 |
|
|
2023
Q3 | $5.99M | Sell |
577,450
-14,938
| -3% | -$155K | 0.06% | 260 |
|
|
2023
Q2 | $8.48M | Sell |
592,388
-6,460
| -1% | -$92.5K | 0.08% | 241 |
|
|
2023
Q1 | $4.28M | Buy |
598,848
+4,691
| +0.8% | +$33.5K | 0.04% | 276 |
|
|
2022
Q4 | $6.67M | Buy |
594,157
+998
| +0.2% | +$11.2K | 0.07% | 242 |
|
|
2022
Q3 | $6.57M | Buy |
593,159
+99,709
| +20% | +$1.1M | 0.07% | 214 |
|
|
2022
Q2 | $4.17M | Buy |
493,450
+13,808
| +3% | +$117K | 0.04% | 246 |
|
|
2022
Q1 | $6.53M | Buy |
479,642
+96,090
| +25% | +$1.31M | 0.06% | 233 |
|
|
2021
Q4 | $7.54M | Buy |
383,552
+158,629
| +71% | +$3.12M | 0.06% | 231 |
|
|
2021
Q3 | $7.22M | Sell |
224,923
-4,495
| -2% | -$144K | 0.06% | 232 |
|
|
2021
Q2 | $7.77M | Buy |
229,418
+29,900
| +15% | +$1.01M | 0.07% | 236 |
|
|
2021
Q1 | $7.49M | Buy |
+199,518
| New | +$7.49M | 0.07% | 233 |
|